Skip to main content
. 2015 Dec 17;4(12):2012–2027. doi: 10.3390/jcm4121957

Table 1.

General patient information.

Cohort Age Gender p16 Mutation Status Melanoma Diagnosis
A1 37 M 377T>A (p.V126D) N
A2 40 M 377T>A (p.V126D) N
A3 37 M 377T>A (p.V126D)) N
A4 46 M 377T>A (p.V126D) N
A5 64 F 377T>A (p.V126D) N
B1 86 M 377T>A (p.V126D) Y
B2 56 M 377T>A (p.V126D) Y
B3 83 M 377T>A (p.V126D) Y
B4 66 F 377T>A (p.V126D) Y
B5 50 M 377T>A (p.V126D) Y
B6 39 F 377T>A (p.V126D) Y
B7 42 F 377T>A (p.V126D) Y
B8 52 F 377T>A (p.V126D) Y
C1 68 M negative N
C2 40 F negative N
C3 41 M negative N
C4 46 M negative N
C5 45 F negative N
C6 36 M negative N
C7 58 M negative N
C8 63 M negative N
C9 88 M negative N
C10 34 F negative N
C11 36 F negative N
C12 40 F negative N
C13 68 F negative N
D1 50 M Not tested met mel
D2 48 F Not tested met mel
D3 38 M Not tested met mel
D4 55 M Not tested met mel
D5 34 M Not tested met mel
D6 81 M Not tested met mel
D7 82 F Not tested met mel
D8 40 M Not tested met mel
D9 40 M Not tested met mel
D10 55 M Not tested met mel